BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7824963)

  • 1. Human pharmacokinetics of glycosaminoglycans using deuterium-labeled and unlabeled substances: evidence for oral absorption.
    Silvestro L; Lanzarotti E; Marchi E; Gori M; Pescador R; Ferro L; Milani MR; Da Col R; Coppini A
    Semin Thromb Hemost; 1994; 20(3):281-92. PubMed ID: 7824963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of deuterium-labeled glycosaminoglycans.
    Naggi A; Casu B; Crippa B; Magnaghi S; Silvestro L; Torri G
    Semin Thromb Hemost; 1994; 20(2):168-75. PubMed ID: 7997888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of dermatan sulfate and oversulfated dermatan sulfate in plasma by high-performance liquid chromatography with postcolumn fluorescence derivatization.
    Huang Y; Washio Y; Hara M; Toyoda H; Koshiishi I; Toida T; Imanari T
    Anal Biochem; 1996 Sep; 240(2):227-34. PubMed ID: 8811915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physico-chemical properties and the structure of dermatan sulfate fractions purified from plasma after oral administration in healthy human volunteers.
    Volpi N
    Thromb Haemost; 1996 Mar; 75(3):491-6. PubMed ID: 8701414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosaminoglycans bind to homologous cardiotoxins with different specificity.
    Vyas KA; Patel HV; Vyas AA; Wu W
    Biochemistry; 1998 Mar; 37(13):4527-34. PubMed ID: 9521773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disaccharide analysis and molecular mass determination to microgram level of single sulfated glycosaminoglycan species in mixtures following agarose-gel electrophoresis.
    Volpi N
    Anal Biochem; 1999 Sep; 273(2):229-39. PubMed ID: 10469494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization and antithrombin activity of dermatan sulfate purified from marine clam Scapharca inaequivalvis.
    Volpi N; Maccari F
    Glycobiology; 2009 Apr; 19(4):356-67. PubMed ID: 19056786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological actions of sulodexide.
    Ofosu FA
    Semin Thromb Hemost; 1998; 24(2):127-38. PubMed ID: 9579633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosaminoglycans: clinical use.
    Boneu B
    Semin Thromb Hemost; 1996; 22(2):209-12. PubMed ID: 8807719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural characterization of the skin glycosaminoglycans in patients with pseudoxanthoma elasticum.
    Maccari F; Volpi N
    Int J Dermatol; 2008 Oct; 47(10):1024-7. PubMed ID: 18986348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of glycosaminoglycans using high-performance liquid chromatography on a hydroxyapatite column.
    Narita H; Takeda Y; Takagaki K; Nakamura T; Harata S; Endo M
    Anal Biochem; 1995 Nov; 232(1):133-6. PubMed ID: 8600821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a liquid chromatographic/tandem mass spectrometric assay for a new endothelin receptor antagonist, and its application to dog plasma samples generated after simultaneous i.v. and p.o. administration of the unlabeled and deuterium-labeled forms of this antagonist.
    Lausecker B; Fischer G
    J Mass Spectrom; 2003 Jun; 38(6):649-58. PubMed ID: 12827634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of dermatan sulfate after intravenous and intramuscular administration to healthy volunteers.
    Blardi P; Messa GL; Urso R; Di Perri T
    Int J Clin Pharmacol Res; 1993; 13(4):231-8. PubMed ID: 8150550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.
    Lappin G; Kuhnz W; Jochemsen R; Kneer J; Chaudhary A; Oosterhuis B; Drijfhout WJ; Rowland M; Garner RC
    Clin Pharmacol Ther; 2006 Sep; 80(3):203-15. PubMed ID: 16952487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of dermatan sulfate in the rabbit after intravenous injection.
    Dol F; Houin G; Dupouy D; Cadroy Y; Caranobe C; Gabaig AM; Mardiguian J; Sié P; Boneu B
    Thromb Haemost; 1988 Apr; 59(2):255-8. PubMed ID: 3388296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic reconstruction of dermatan sulfate.
    Takagaki K; Munakata H; Kakizaki I; Majima M; Endo M
    Biochem Biophys Res Commun; 2000 Apr; 270(2):588-93. PubMed ID: 10753668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein.
    Westphal K; Weinbrenner A; Giessmann T; Stuhr M; Franke G; Zschiesche M; Oertel R; Terhaag B; Kroemer HK; Siegmund W
    Clin Pharmacol Ther; 2000 Jul; 68(1):6-12. PubMed ID: 10945310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional changes of sulfated glycosaminoglycans in Xenopus laevis during embryogenesis.
    Yamada S; Onishi M; Fujinawa R; Tadokoro Y; Okabayashi K; Asashima M; Sugahara K
    Glycobiology; 2009 May; 19(5):488-98. PubMed ID: 19190026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.